Various advanced cancer
Clinical trials for Various advanced cancer explained in plain language.
Never miss a new study
Get alerted when new Various advanced cancer trials appear
Sign up with your email to follow new studies for Various advanced cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy drug aims to keep bladder cancer from returning after surgery
Disease control CompletedThis phase 3 trial tests whether the immunotherapy drug nivolumab can delay cancer recurrence in people who have had surgery for high-risk invasive urothelial cancer (a type of bladder cancer). About 709 participants received either nivolumab or a placebo after surgery. The main …
Matched conditions: VARIOUS ADVANCED CANCER
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Immunotherapy duo shows promise against tough esophageal cancer
Disease control CompletedThis phase 3 trial tested whether adding immunotherapy drugs (nivolumab and ipilimumab) to standard chemotherapy helps people with advanced esophageal cancer live longer or keep their cancer from growing. About 970 participants with inoperable or metastatic esophageal squamous ce…
Matched conditions: VARIOUS ADVANCED CANCER
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC